论文信息 - 1080 Preclinical and Toxicological Assessments of the Novel Orally Bioavailable PPAR Ligand GED-0507-34-Levo for the Treatment of Inflammatory Bowel Disease - 字舞流文

1080 Preclinical and Toxicological Assessments of the Novel Orally Bioavailable PPAR Ligand GED-0507-34-Levo for the Treatment of Inflammatory Bowel Disease

P. Chavatte | P. Desreumaux | J. Colombel | F. Viti | C. Dubuquoy | C. Rousseaux | S. Bellinvia